Abstract
Ferrocytochrome b562 [Fe(II)cyt b562] folding can be triggered by photoinduced electron transfer to unfolded Fe(III)cyt b562 in 2–3 M guanidine hydrochloride solutions. The folding rates increase with decreasing guanidine hydrochloride; the extrapolated time constant for this folding process in the absence of denaturant (5 μs) is near the predicted value for intrachain diffusion. The relatively smooth energy landscape indicated for Fe(II)cyt b562 folding accords with the helical, highly symmetrical structure of the protein.
Keywords: protein folding, guanidine hydrochloride, contact order
Spontaneous refolding of proteins occurs on timescales that range from microseconds to hours (1–10). Cytochrome b562 (cyt b562), a soluble 106-residue heme protein from Escherichia coli (11–14), folds relatively rapidly (9, 15). The protein is comprised of four antiparallel α-helices that wrap into a left-handed bundle; the heme is inserted among the helices, axially ligated by Met7 and His102 (Fig. 1) (16). The heme reduction potential in the folded state [189 mV vs. normal hydrogen electrode (pH 7) (17)] is ≈330 mV higher than in the unfolded form [−150 mV (18, 19)], indicating that the driving force for folding is greater for the reduced than for the oxidized protein (9, 15, 20, 21). Guanidine hydrochloride (GuHCl) reversibly unfolds the oxidized protein with a midpoint at 1.8 M (pH 7). Unfolding the reduced protein requires a GuHCl concentration >5 M and, owing to heme dissociation, is irreversible. Under suitable denaturing conditions (2 M ≤ [GuHCl] ≤ 3 M), electron transfer to unfolded Fe(III)cyt b562 initiates folding of the reduced protein. Earlier, it was reported that the native low-spin Fe(II) protein forms ≈1 ms after photochemical electron transfer to unfolded Fe(III)cyt b562 (15).
We have investigated the dependence of the Fe(II)cyt b562 folding kinetics on GuHCl concentration. Extrapolation of the observed rate constants to zero denaturant concentration suggests that the folding of this four-helix-bundle in water approaches the theoretical speed limit for intrachain diffusion of the polypeptide.
MATERIALS AND METHODS
Guanidine hydrochloride (Sigma, ultrapure grade), tris(2, 2′-bipyridine)ruthenium(II) chloride (Strem, Newburyport, MA), and 1,4-dihydronicotinamide adenine dinucleotide (NADH, Sigma) were used as received. Para-methoxydimethylaniline (pMDMA) was synthesized according to a published procedure (22).
Plasmid (pNS207), containing the cytochrome b562 gene (provided by S. G. Sligar, University of Illinois), was expressed in E. coli (strain BL21). Cyt b562 was isolated and purified according to a procedure given by Farrow (23). The purity of proteins used in all experiments was assessed from the 418:280 nm absorbance (A418/A280 = 5.6–6.0). Protein concentrations were determined by using the extinction coefficients ɛ418 = 0.117 μM−1⋅cm−1 [Fe(III)] and ɛ426 = 0.180 μM−1⋅cm−1 [Fe(II)] (12, 24). Unfolding curves for Fe(III)- and Fe(II)cyt b562 were generated from absorption and far-UV circular dichroism spectra according to standard procedures (25). In experiments with the Fe(II) protein, a slight excess of sodium dithionite was added to keep the unfolded protein in the reduced state. GuHCl stock solutions were adjusted to pH 7.0–7.1 by using 1.0 M NaOH. The concentration of GuHCl was determined through measurements of the solution refractive index (Milton Roy Abbe-3L Refractometer) (25).
Steady-state absorption spectra were measured on a Hewlett–Packard 8452 diode array spectrophotometer. Circular dichroism spectra were obtained by using an Aviv 62ADS spectropolarimeter (Aviv Associates, Lakewood, NJ). Transient absorption kinetics measurements were made as described (26). The excitation source was a XeCl excimer-pumped dye laser (480 nm, 25 ns, 1–4 mJ) in experiments with Ru(bpy)32+ and the third harmonic (355 nm) of a Q-switched Nd:YAG laser in experiments using NADH as the photoreductant. Samples for folding kinetics measurements were held in 1-mm sealed cuvettes (0.8–1.5 ml) and contained the following: cyt b562 (15–100 μM); either Ru(bpy)32+ (1.0–1.5 equivalent) and pMDMA (≈10 mM) or NADH (2.0–2.5 equivalent); and GuHCl (2–3 M, pH 6.6). Samples were deoxygenated by repeated evacuation/Ar-fill cycles on a Schlenk line. At each GuHCl concentration, the reported rate constant is an average of several kinetics traces.
The yield of folded reduced protein (Φf), relative to unfolded reduced protein generated by laser excitation, was calculated from initial and final absorption changes at each GuHCl concentration. The extinction coefficient for the unfolded reduced protein was determined by using a reductive flash quench procedure. Laser-excited Ru(bpy)32+ was quenched with pMDMA to generate Ru(bpy)3+ and pMDMA⋅+. The concentrations of the charge separated products were determined from their molar difference spectra. The photochemically generated Ru(bpy)3+ reduces unfolded Fe(III)cyt b562 in <10 μs. On complete reduction of the heme, the transient spectrum contains contributions from pMDMA•+ and unfolded Fe(II)cyt b562 at known concentrations. Extinction coefficients for unfolded Fe(II)cyt b562 then were determined from the transient kinetics at various wavelengths by subtracting the contribution from pMDMA•+.
The observed rate constant (kobsd) was interpreted as the sum of a folding rate constant (kf) and a dissociation rate constant (kdiss):
Folding rate constants were extracted from observed rates by using the spectroscopically determined folding yields.
RESULTS
The absorption spectra of the oxidized and reduced states of folded cyt b562 show Soret-region features that are characteristic of low-spin d5 and d6 hemes (19). On GuHCl denaturation of Fe(III)cyt b562, the Soret absorption blue-shifts, broadens, and loses intensity at the maximum; these changes in the spectrum reflect the formation of a high-spin d5 heme (Fig. 2). GuHCl titrations probed by changes in absorbance or circular dichroism spectra indicate that the unfolding midpoint for Fe(III)cyt b562 (1.8 M) is much lower than that for reduced protein (5.7 M) (Fig. 3). The unfolded oxidized protein spontaneously refolds on dilution of GuHCl, confirming that the heme stays bound to the polypeptide for protein concentrations >10 μM (27). Unfolded Fe(II)cyt b562, however, does not readily refold on dilution of the denaturant; heme dissociation is likely responsible for this behavior. Between 2 and 3 M GuHCl (pH 7), a significant amount of folded Fe(II)cyt b562 is observed on addition of sodium dithionite to solutions of unfolded Fe(III)cyt b562 (2.33 M GuHCl, 50% yield; 3.02 M, 30%). At higher GuHCl concentrations, heme dissociation from the peptide appears to be faster than protein folding. Measurements of Fe(II)cyt b562 kinetics were, therefore, confined to the 2–3 M GuHCl concentration range.
The folding of Fe(II)cyt b562 was initiated by laser excitation (355 nm) of NADH to produce two powerful reductants, a solvated electron and the NAD• radical (15, 28, 29). The initial transient spectrum (<100 μs) reflects formation of reduced unfolded protein. The transient spectrum recorded 10 ms after excitation (2.5 M GuHCl) agrees well with steady-state absorption differences between unfolded Fe(III)cyt b562 and folded Fe(II)cyt b562 (15), indicating that folding has occurred on this timescale. Kinetics were monitored by Soret absorption changes (400–430 nm) that indicate the formation of a low-spin ferroheme. The folding reactions were slower at higher GuHCl concentrations; the observed first-order rate constants (kobsd) range from 3.3(7) × 103 to 7.4(9) × 103 s−1 (2–3 M GuHCl). Specific rate constants for formation of low-spin folded cyt b562, extracted from the observed rate constants, vary from 1.5(2) × 103 (2.2 M GuHCl) to 3.0(9) × 102 s−1 (3.0 M GuHCl) (Fig. 4). (The rate constants for the competing heme-dissociation process range from 3 to 7 × 103 s−1 between 2 and 3 M GuHCl.) Although a relatively narrow range of GuHCl concentrations was explored, there appears to be a linear relationship between the logarithm of the folding rate and the GuHCl concentration (Fig. 4). Extrapolation to 0 M GuHCl suggests a time constant of ≈5 μs for folding Fe(II)cyt b562 in water.‡
DISCUSSION
A recent molecular-dynamics simulation carried out on an unfolded 36-residue protein suggests that partly folded structures can occur within tens of nanoseconds (30). Experimental studies on apomyoglobin (134 residues) indicate that some secondary structure forms in the first 10 μs of folding (31, 32). Polymer diffusion models have been used to estimate that the minimum time constant for folding a small, single-domain protein to its native structure is on the order of 1 μs (8, 33). More recent estimates suggest a lower limit of 0.2 μs for protein folding (34). Our extrapolated folding time for Fe(II)cyt b562 approaches this limit.
Another four-helix bundle, the acyl CoA binding protein (ACBP), folds more slowly than Fe(II)cyt b562 [700 s−1, 20°C (35, 36)]. ACBP has a so-called up-down-down-up four-helix bundle structure held together by hydrophobic junctions, where the helices interact pairwise or in groups of three (37). By contrast, the cyt b562 bundle is an up-down-up-down arrangement, and the four helices are almost perfectly parallel to each other (16). ACBP is less stable than Fe(II) cyt b562 [−ΔGf = 29 (35, 36) and ≈43 kJ/mol (15), respectively], a property that may affect the folding kinetics, because, in general, the tertiary folds of these two proteins are similar. Although reduced horse heart cytochrome c is much more stable [−ΔGf = 74 kJ/mol (38)] than Fe(II)cyt b562, it folds much more slowly [estimated folding time of 100 μs in aqueous solution (20, 28, 38)]. Part of the difference is undoubtedly attributable to ligand substitution kinetics that retard the folding of cytochrome c (28). But even at reduced pH, where the heme in unfolded cytochrome c is not misligated, protein folding is still slower than for cyt b562 (5).
Why does folding of Fe(II)cyt b562 occur near the maximum speed limit when the folding of other helical proteins is much slower? Theoretical analysis indicates that symmetrical structures will have relatively smooth energy landscapes for folding (1, 39), and the up-down-up-down four-helix-bundle structure of cytochrome b562 is one of the most symmetrical of protein architectures. It is interesting to note that an inverse correlation between folding rates and contact order (the average relative sequence separation of native contacts) has been observed for a set of single-domain proteins that exhibit two-state folding (40). Although two-state folding has not yet been confirmed in cyt b562, the contact order of this protein is extremely low, 7.5% (K. W. Plaxco, personal communication), which is consistent with its very local, all helical structure (16). This low contact order corresponds to a predicted folding time of ≈10 μs, which is in good agreement with our extrapolated value of 5 μs. The longer folding times of the helical proteins cytochrome c and ACBP (20, 28, 35, 36, 38) are consistent with the predictions of the contact-order model (contact orders: cyt c, 11.2%; ACBP, 14%) (40).
The fast folding observed for cyt b562 may be a consequence of the competing heme-dissociation step. Unfolded cyt b562 is expected to be an ensemble of randomly configured, heme-bound polypeptides. The kinetics for conversion of this ensemble into a homogeneous population of folded proteins could be highly heterogenous. Some configurations in the unfolded ensemble could fold quite rapidly whereas others might require much longer times (41). This division of the unfolded ensemble into fast and slow folding populations can have important implications when a second process competes with folding. In Fe(II)cyt b562, it is possible that only fast folding is observed because the heme dissociates from the slow-folding configurations. Because the free heme has a relatively weak spectroscopic signature, its presence would be difficult to detect amid a population of folded reduced protein. If heme dissociation does select against slow folding configurations in Fe(II)cyt b562, then we expect that four-helix bundle c-type heme proteins [e.g., cytochrome c′ (11, 42)] would require much longer times to form fully folded ensembles.
Acknowledgments
We thank Kevin Plaxco and Peter Wolynes for communication of unpublished results as well as several stimulating discussions. P.W.-S. acknowledges a postdoctoral fellowship from the Swedish Technical Research Council. J.C.L. acknowledges a graduate fellowship from the Ralph M. Parsons Foundation. This work was supported by the National Science Foundation (Grant MCB 9630465).
ABBREVIATIONS
- ACBP
acyl CoA binding protein
- bpy
2,2′-bipyridine
- cyt b562
cytochrome b562
- GuHCl
guanidine hydrochloride
- pMDMA
para-methoxydimethylaniline
Footnotes
Note that the highest measured rate is 1.5 × 103 s−1 (at 2.2 M GuHCl).
References
- 1.Onuchic J N, Lutheyschulten Z, Wolynes P G. Annu Rev Phys Chem. 1997;48:545–600. doi: 10.1146/annurev.physchem.48.1.545. [DOI] [PubMed] [Google Scholar]
- 2.Shakhnovich E I. Curr Opin Struct Biol. 1997;7:29–40. doi: 10.1016/s0959-440x(97)80005-x. [DOI] [PubMed] [Google Scholar]
- 3.Dobson C M, Sali A, Karplus M. Angew Chem Int Ed Eng. 1998;37:868–893. doi: 10.1002/(SICI)1521-3773(19980420)37:7<868::AID-ANIE868>3.0.CO;2-H. [DOI] [PubMed] [Google Scholar]
- 4.Dill K A, Chan H S. Nat Struct Biol. 1997;4:10–19. doi: 10.1038/nsb0197-10. [DOI] [PubMed] [Google Scholar]
- 5.Englander S W, Sosnick T R, Mayne L C, Shtilerman M, Qi P X, Bai Y. Acc Chem Res. 1998;31:737–744. [Google Scholar]
- 6.Shastry M C R, Sauder J M, Roder H. Acc Chem Res. 1998;31:717–725. [Google Scholar]
- 7.Yeh S-R, Han S, Rousseau D L. Acc Chem Res. 1998;31:727–736. [Google Scholar]
- 8.Eaton W A, Muñoz V, Thompson P A, Henry E R, Hofrichter J. Acc Chem Res. 1998;31:745–753. [Google Scholar]
- 9.Telford J R, Wittung-Stafshede P, Gray H B, Winkler J R. Acc Chem Res. 1998;31:755–763. [Google Scholar]
- 10.Dodge R W, Scheraga H A. Biochemistry. 1996;35:1548–1559. doi: 10.1021/bi952348q. [DOI] [PubMed] [Google Scholar]
- 11.Moore G R, Pettigrew G W. Cytochromes c: Evolutionary, Structural, and Physicochemical Aspects. New York: Springer; 1990. [Google Scholar]
- 12.Itagaki E, Hager L P. J Biol Chem. 1966;241:3687–3695. [PubMed] [Google Scholar]
- 13.Itagaki E, Palmer G, Hager L P. J Biol Chem. 1967;242:2272–2277. [PubMed] [Google Scholar]
- 14.Nikkila H, Gennis R B, Sligar S G. Eur J Biochem. 1991;202:309–313. doi: 10.1111/j.1432-1033.1991.tb16377.x. [DOI] [PubMed] [Google Scholar]
- 15.Wittung-Stafshede P, Gray H B, Winkler J R. J Am Chem Soc. 1997;119:9562–9563. [Google Scholar]
- 16.Hamada K, Bethge P H, Mathews F S. J Mol Biol. 1995;247:947–962. doi: 10.1006/jmbi.1995.0192. [DOI] [PubMed] [Google Scholar]
- 17.Barker P D, Butler J L, de Oliveira P, Hill H A O, Hunt N I. Inorg Chim Acta. 1996;252:71–77. [Google Scholar]
- 18.Bixler J, Bakker G, McLendon G. J Am Chem Soc. 1992;114:6938–6939. [Google Scholar]
- 19.Tezcan F A, Winkler J R, Gray H B. J Am Chem Soc. 1998;120:13383–13388. [Google Scholar]
- 20.Pascher T, Chesick J P, Winkler J R, Gray H B. Science. 1996;271:1558–1560. doi: 10.1126/science.271.5255.1558. [DOI] [PubMed] [Google Scholar]
- 21.Winkler J R, Wittung-Stafshede P, Leckner J, Malmström B G, Gray H B. Proc Natl Acad Sci USA. 1997;94:4246–4249. doi: 10.1073/pnas.94.9.4246. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Sekiya M, Leonard N J. J Org Chem. 1968;33:318–312. [Google Scholar]
- 23.Farrow N A. Ph.D. thesis. Pasadena, CA: California Institute of Technology; 1999. [Google Scholar]
- 24.Moore G R, Williams R J P, Peterson J, Thomson A J, Mathews F S. Biochim Biophys Acta. 1985;829:83–96. doi: 10.1016/0167-4838(85)90071-8. [DOI] [PubMed] [Google Scholar]
- 25.Pace N C, Shirley B A, Thomson J A. In: Protein Structure: A Practical Approach. Creighton T F, editor. Oxford: IRL; 1990. pp. 311–330. [Google Scholar]
- 26.Stowell M H B, Larsen R W, Winkler J R, Rees D C, Chan S I. J Phys Chem. 1993;97:3054–3057. [Google Scholar]
- 27.Robinson C R, Liu Y, Thomson J A, Sturtevant J M, Sligar S G. Biochemistry. 1997;36:16141–16146. doi: 10.1021/bi971470h. [DOI] [PubMed] [Google Scholar]
- 28.Telford J R, Tezcan F A, Gray H B, Winkler J R. Biochemistry. 1999;38:1944–1949. doi: 10.1021/bi981933z. [DOI] [PubMed] [Google Scholar]
- 29.Orii Y. Biochemistry. 1993;32:11910–11914. doi: 10.1021/bi00095a021. [DOI] [PubMed] [Google Scholar]
- 30.Duan Y, Wang L, Kollman P A. Proc Natl Acad Sci USA. 1998;95:9897–9902. doi: 10.1073/pnas.95.17.9897. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Gruebele M, Sabelko J, Ballew R, Ervin J. Acc Chem Res. 1998;31:699–707. [Google Scholar]
- 32.Dyer R B, Gai F, Woodruff W H, Gilmanshin R, Callender R H. Acc Chem Res. 1998;31:709–716. [Google Scholar]
- 33.Hagen S J, Hofrichter J, Szabo A, Eaton W A. Proc Natl Acad Sci USA. 1996;93:11615–11617. doi: 10.1073/pnas.93.21.11615. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Thirumalai D. J Phys Chem B. 1999;103:608–610. [Google Scholar]
- 35.Kragelund B B, Robinson C V, Knudsen J, Dobson C M, Poulsen F M. Biochemistry. 1995;34:7217–7224. doi: 10.1021/bi00021a037. [DOI] [PubMed] [Google Scholar]
- 36.Kragelund B B, Højrup P, Jensen M S, Schjerling C K, Juul E, Knudsen J, Poulsen F M. J Mol Biol. 1996;256:187–200. doi: 10.1006/jmbi.1996.0076. [DOI] [PubMed] [Google Scholar]
- 37.Andersen K V, Poulsen F. J Mol Biol. 1992;226:1131–1141. doi: 10.1016/0022-2836(92)91057-v. [DOI] [PubMed] [Google Scholar]
- 38.Mines G A, Pascher T, Lee S C, Winkler J R, Gray H B. Chem Biol. 1996;3:491–497. doi: 10.1016/s1074-5521(96)90097-6. [DOI] [PubMed] [Google Scholar]
- 39.Wolynes P G. Proc Natl Acad Sci USA. 1996;93:14249–14255. doi: 10.1073/pnas.93.25.14249. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Plaxco K W, Simons K T, Baker D. J Mol Biol. 1998;277:985–994. doi: 10.1006/jmbi.1998.1645. [DOI] [PubMed] [Google Scholar]
- 41.Guo Z, Thirumalai D. J Mol Biol. 1996;263:323–343. doi: 10.1006/jmbi.1996.0578. [DOI] [PubMed] [Google Scholar]
- 42.Bertini I, Dikiy A, Luchinat C, Macinai R, Viezzoli M S. Inorg Chem. 1998;37:4814–4821. doi: 10.1021/ic980531c. [DOI] [PubMed] [Google Scholar]